Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Personalis Inc (PSNL)

Personalis Inc (PSNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,807
  • Shares Outstanding, K 51,939
  • Annual Sales, $ 73,480 K
  • Annual Income, $ -108,300 K
  • 60-Month Beta 1.86
  • Price/Sales 0.85
  • Price/Cash Flow N/A
  • Price/Book 0.51
Trade PSNL with:

Options Overview Details

View History
  • Implied Volatility 269.29% ( +129.86%)
  • Historical Volatility 99.55%
  • IV Percentile 54%
  • IV Rank 20.27%
  • IV High 1,157.51% on 10/20/23
  • IV Low 43.48% on 08/08/23
  • Put/Call Vol Ratio 0.03
  • Today's Volume 63
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,457
  • Open Int (30-Day) 1,181

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.32
  • Low Estimate -0.36
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1350 +34.80%
on 07/01/24
1.5400 -0.65%
on 07/05/24
+0.0600 (+4.08%)
since 06/05/24
3-Month
1.1350 +34.80%
on 07/01/24
1.8500 -17.30%
on 05/03/24
+0.1400 (+10.07%)
since 04/05/24
52-Week
0.8906 +71.79%
on 11/10/23
2.4300 -37.04%
on 07/19/23
-0.3700 (-19.47%)
since 07/05/23

Most Recent Stories

More News
Personalis: Q1 Earnings Snapshot

Personalis: Q1 Earnings Snapshot

PSNL : 1.5300 (+28.57%)
Personalis: Q4 Earnings Snapshot

Personalis: Q4 Earnings Snapshot

PSNL : 1.5300 (+28.57%)
Personalis: Q3 Earnings Snapshot

Personalis: Q3 Earnings Snapshot

PSNL : 1.5300 (+28.57%)
Personalis: Q2 Earnings Snapshot

Personalis: Q2 Earnings Snapshot

PSNL : 1.5300 (+28.57%)
Personalis: Q1 Earnings Snapshot

Personalis: Q1 Earnings Snapshot

PSNL : 1.5300 (+28.57%)
Personalis Reports First Quarter 2023 Financial Results

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the first quarter ended March 31, 2023 and provided recent business highlights....

PSNL : 1.5300 (+28.57%)
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer

Personalis, Inc. (Nasdaq: PSNL) today announced it has partnered with the Academic Breast Cancer Consortium (ABRCC) and Criterium to carry out a prospective clinical trial, B-STRONGER-1 (Breast Cancer-Minimal...

PSNL : 1.5300 (+28.57%)
Personalis to Announce First Quarter 2023 Financial Results

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results on Wednesday, May 3, 2023. In conjunction...

PSNL : 1.5300 (+28.57%)
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference...

PSNL : 1.5300 (+28.57%)
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study

Personalis, Inc. (Nasdaq: PSNL), Cancer Research UK’s Cancer Research Horizons, University College London (UCL), and the Francis Crick Institute today announced a collaboration to deploy NeXT Personal...

PSNL : 1.5300 (+28.57%)

Business Summary

Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.

See More

Key Turning Points

3rd Resistance Point 1.9867
2nd Resistance Point 1.7633
1st Resistance Point 1.6467
Last Price 1.5300
1st Support Level 1.3067
2nd Support Level 1.0833
3rd Support Level 0.9667

See More

52-Week High 2.4300
Fibonacci 61.8% 1.8419
Fibonacci 50% 1.6603
Last Price 1.5300
Fibonacci 38.2% 1.4787
52-Week Low 0.8906

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar